# Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

> **NCT07333430** · PHASE1 · RECRUITING · sponsor: **Hadassah Medical Organization** · enrollment: 60 (estimated)

## Conditions studied

- Relapsed/Refractory Multiple Myeloma (MM)

## Interventions

- **BIOLOGICAL:** Naive HBI0101 CAR-T

## Key facts

- **NCT ID:** NCT07333430
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333430, "Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07333430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*